APA
Castañón E., Rolfo C., Viñal D., López I., Fusco J. P., Santisteban M., Martin P., Zubiri L., Echeveste J. I. & Gil-Bazo I. (20160317). Impact of epidermal growth factor receptor (EGFR) activating mutations and their targeted treatment in the prognosis of stage IV non-small cell lung cancer (NSCLC) patients harboring liver metastasis. : Journal of translational medicine.
Chicago
Castañón Eduardo, Rolfo Christian, Viñal David, López Inés, Fusco Juan P, Santisteban Marta, Martin Patricia, Zubiri Leire, Echeveste José I and Gil-Bazo Ignacio. 20160317. Impact of epidermal growth factor receptor (EGFR) activating mutations and their targeted treatment in the prognosis of stage IV non-small cell lung cancer (NSCLC) patients harboring liver metastasis. : Journal of translational medicine.
Harvard
Castañón E., Rolfo C., Viñal D., López I., Fusco J. P., Santisteban M., Martin P., Zubiri L., Echeveste J. I. and Gil-Bazo I. (20160317). Impact of epidermal growth factor receptor (EGFR) activating mutations and their targeted treatment in the prognosis of stage IV non-small cell lung cancer (NSCLC) patients harboring liver metastasis. : Journal of translational medicine.
MLA
Castañón Eduardo, Rolfo Christian, Viñal David, López Inés, Fusco Juan P, Santisteban Marta, Martin Patricia, Zubiri Leire, Echeveste José I and Gil-Bazo Ignacio. Impact of epidermal growth factor receptor (EGFR) activating mutations and their targeted treatment in the prognosis of stage IV non-small cell lung cancer (NSCLC) patients harboring liver metastasis. : Journal of translational medicine. 20160317.